Sobera Capital acquires international portfolio of direct interests from Innoveas
Sobera Capital has acquired a portfolio of 12 minority and majority equity holdings in private companies mainly in the life sciences sector from Innoveas International Ltd. The assets, which include, among others, interests in Presidio Pharmaceuticals, EffRx Pharmaceuticals, MORE Medical Solutions, Axellis Ventures and MyoScience, are based mainly in Europe